NCT03395418View on ClinicalTrials.gov

Evaluation of the Right Use of Inhaled Therapeutics

CompletedOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

December 1, 2017

Primary Completion Date

September 1, 2019

Study Completion Date

November 1, 2019

Conditions
COPD Asthma
Trial Locations (1)

75006

ANTADIR, Paris

All Listed Sponsors
lead

Association Nationale pour les Traitements A Domicile, les Innovations et la Recherche

OTHER

NCT03395418 - Evaluation of the Right Use of Inhaled Therapeutics | Biotech Hunter | Biotech Hunter